Our Partners

INSTITUTION:

MRCG – MRC Unit The Gambia

Visit Website

QUICK FACTS

Our portfolio covers research and evaluation of interventions for disease control among populations in sub-Saharan Africa.
The MRC Unit The Gambia (MRCG) is one of two research units established in sub-Saharan Africa by the Medical Research Council UK and is the MRC’s largest single investment in medical research in a low- and middle-income country. MRC Unit The Gambia at the LSHTM represents an outstanding concentration of scientific expertise and high-quality research platforms in West Africa. The Unit’s investigator-led research is underpinned by excellent laboratory facilities, easy access to the field, and well-defined populations that are highly supportive of our research. It provides excellent clinical services, upholds rigorous ethical procedures and has been delivering GCP-compliant clinical trials. Our portfolio covers research and evaluation of interventions for disease control among populations in sub-Saharan Africa.  
About Us
Aim: To unveil the impacts of environmental heat exposures such as high ambient temperature, drought, rainfall, flooding on access to antenatal care (ANC) and postnatal care (PNC) services as well as on maternal, newborn and child mortality in Senegal and The Gambia
Quick Links
Contacts
Address
Dakar, Senegal
Phone Number
+221 33 867 99 36
Email
ech@aphrc.org

Copyright © 2026. CHARTer. All Rights Reserved.

The MRC Unit The Gambia (MRCG) is one of two research units established in sub-Saharan Africa by the Medical Research Council UK and is the MRC’s largest single investment in medical research in a low- and middle-income country. MRC Unit The Gambia at the LSHTM represents an outstanding concentration of scientific expertise and high-quality research platforms in West Africa. The Unit’s investigator-led research is underpinned by excellent laboratory facilities, easy access to the field, and well-defined populations that are highly supportive of our research. It provides excellent clinical services, upholds rigorous ethical procedures and has been delivering GCP-compliant clinical trials. Our portfolio covers research and evaluation of interventions for disease control among populations in sub-Saharan Africa.